1.Advance of in vitro oral static biofilm model.
Huabing ZHAO ; Tingting SHI ; Fengzhu LI ; Rui WANG ; Fuping LU ; Zhengmei HUANG
Chinese Journal of Biotechnology 2022;38(9):3267-3278
		                        		
		                        			
		                        			Oral static biofilm model is an important tool for in vitro simulation of oral microecological environment, which has become an important method for studying the pathogenesis of various oral diseases and testing the efficacy of various drugs, oral care products and foods due to its low cost, high throughput, good reliability and easy operation. The establishment of oral static biofilm models allows the selection of different devices, inoculum sources, media, substrates and culture conditions according to the purpose of the study, and the evaluation of biofilm growth by various methods such as measuring biomass, metabolic activity, community structure and performing visualization analysis. This paper summarizes the methodological elements reported in recent years for the establishment and evaluation of oral static biofilm models, and analyzes and discusses the applicability of various methods in the hope of contributing to the research and production practice in related fields.
		                        		
		                        		
		                        		
		                        			Biofilms
		                        			;
		                        		
		                        			Reproducibility of Results
		                        			
		                        		
		                        	
2.Recent advance in Spadin and its analogs in treatment of post-stroke depression
Xiuli WANG ; Wei WEI ; Cui FANG ; Mengyao ZHANG ; Fuping SHI
Chinese Journal of Neuromedicine 2021;20(9):956-959
		                        		
		                        			
		                        			Post-stroke depression (PSD) is one kind of the common mental diseases after stroke, and the prevention and treatment of PSD are very difficult. TREK-1, a two-pore domain potassium channel, is an important target in the pathogenesis of stroke and PSD, and it is closely related to neuroprotection and emotion regulation; inhibition of activity of TREK-1 channel can exert significant antidepressant effect. In recent years, TREK-1 channel blocker Spadin and Spadin analogs are discovered, and they have a relatively significant effect on ischemic stroke and PSD. In this paper, the research progress on the discovery, efficacy and therapeutic value of Spadin and Spadin analogs in PSD are summarized as follows.
		                        		
		                        		
		                        		
		                        	
3.Correlation between fluid-attenuated inversion recovery vascular hyperintensities and outcomes after endovascular mechanical thrombectomy in patients with anterior circulation large vessel occlusive stroke
Nihong CHEN ; Hongdong ZHAO ; Fuping JIANG ; Hongchao SHI ; Jiankang HOU ; Chencheng WEI
International Journal of Cerebrovascular Diseases 2020;28(8):574-580
		                        		
		                        			
		                        			Objective:To investigate the correlation between fluid-attenuated inversion recovery (FLAIR) vascular hyperintensities (FVHs) and outcomes after endovascular mechanical thrombectomy (EMT) in patients with anterior circulation large vessel occlusive stroke.Methods:Using " Nanjing First Hospital Stroke Database" , consecutive patients with anterior circulation large vessel occlusive stroke received EMT treatment from June 2015 to December 2018 were enrolled retrospectively. Before EMT treatment, the distal FVH grade and the American Society of Intervention and Therapeutic Neuroradiology/Society of Interventional Radiology (ASITN/SIR) collateral circulation grade were evaluated. The modified Rankin Scale was used to evaluate the functional outcome of patients at 3 months after onset, and 0-2 was defined as a good outcome. Spearman correlation analysis was used to analyze the correlation between the distal FVH grade and the ASITN/SIR collateral circulation grade. Multivariate logistic regression analysis was used to identify the independent predictors of the outcomes. Results:A total of 117 patients with acute anterior circulation large vessel occlusive stroke were enrolled, aged 70.74±12.50 years, 72 (61.5%) were male. The baseline National Institutes of Health Stroke Scale (NIHSS) score was 13.73±4.91. Seventy-four patients (63.2%) had a good outcome and 43 (36.8%) had a poor outcome. The distal FVH grade was grade 0 in 8 cases (6.84%), grade 1 in 34 cases (29.06%), and grade 2 in 75 cases (64.10%). Compared with the distal FVH low-grade group (grade 0-1), the high-grade group (grade 2) had a higher ASITN/SIR collateral circulation grade ( P<0.001) and lower baseline National Institutes of Health Stroke Scale (NIHSS) score ( P=0.026). Spearman correlation analysis showed that the distal FVH grade was significantly positively correlated with the ASITN/SIR collateral circulation grade ( r=0.620, P<0.001). Multivariate logistic regression analysis showed that the high distal FVH grade (odds ratio [ OR] 0.336, 95% confidence interval [ CI] 0.128-0.879; P=0.026) was independently associated with the good outcomes, while the higher baseline NIHSS score ( OR 1.036, 95% CI 0.988-1.229; P=0.048) and symptomatic cerebral hemorrhage ( OR 5.597, 95% CI 1.052-29.761; P=0.043) were independently associated with the poor outcomes. Conclusion:The distal FVHs can reflect the state of collateral circulation. The high grade of distal FVHs is associated with the good outcomes after EMT in patients with anterior circulation large vessel occlusive stroke.
		                        		
		                        		
		                        		
		                        	
4.Effect of different doses of atorvastatin on early neurological deterioration and short-term outcomes in patients with acute ischemic stroke
Nihong CHEN ; Junshan ZHOU ; Fuping JIANG ; Yukai LIU ; Zhonghua ZHANG ; Yanyan SHI
International Journal of Cerebrovascular Diseases 2014;22(11):848-852
		                        		
		                        			
		                        			Objective To intestate the effect of different doses of atorvastatin on early neurological deterioration and short-term outcomes in patients with acute ischemic stroke.Methods The patients with acute ischemic stroke were enrolled prospectively.They were randomly assigned to either a standard therapy group (atorvastatin 20 mg/d) or an intensive treatment group (atorvastatin 40 mg/d).The primary outcomes were early neurological deterioration within 1 week of treatment and the good outcome of evaluation at 1 month after treatment (the modified Rankin Scale score 0-2); the secondary outcomes were the National Institutes of Health Stroke Scale (NIHSS) score and adverse events at 1 month.Results A total of 125 patients with acute ischemic stroke were enrolled,including 62 in the standard therapy group and 63 in the intensive treatment group.The incidence of early neurological deterioration at 1 week after treatment in the standard therapy group was significantly higher than that in the intensive treatment group (16.13% vs.4.76%;x2=4.333,P=0.038); the proportion of good outcome in the standard therapy group was significantly lower than that in the intensive treatment group at 1 month after treatment (53.23% vs.71.43% ;x2 =4.413,P=0.036).During the treatment,no significant liver damage,muscle toxicity and other adverse events of causing atorvastatin reduction or withdrawal occurred in the patients of both groups.Conclusions Using high-dose atorvastatin in the acute phase of ischemic stroke may decrease the incidence of early neurological deterioration compared with the conventional dose,and improve short-term clinical outcomes.
		                        		
		                        		
		                        		
		                        	
5.High-efficiency L-lactate production from glycerol by metabolically engineered Escherichia coli.
Kangming TIAN ; Guiyang SHI ; Fuping LU ; Suren SINGH ; Zhengxiang WANG
Chinese Journal of Biotechnology 2013;29(9):1268-1277
		                        		
		                        			
		                        			High-efficient conversion of glycerol to L-lactate is beneficial for the development of both oil hydrolysis industry and biodegradable materials manufacturing industry. In order to construct an L-lactate producer, we first cloned a coding region of gene BcoaLDH encoding an L-lactate dehydrogenase from Bacillus coagulans CICIM B1821 and the promoter sequence (P(ldhA)) of the D-lactate dehydrogenase (LdhA) from Escherichia coli CICIM B0013. Then we assembled these two DNA fragments in vitro and yielded an expression cassette, P(ldhA)-BcoaLDH. Then, the cassette was chromosomally integrated into an ldhA mutant strain, Escherichia coli CICIM B0013-080C, by replacing lldD encoding an FMN-dependent L-lactate dehydrogenase. An L-lactate higher-producer strain, designated as E. coli B0013-090B, possessing genotype of lldD::P(ldhA)-BcoaLDH, deltaack-pta deltapps deltapflB deltadld deltapoxB deltaadhE deltafrdA and deltaldhA, was generated. Under the optimal condition, 132.4 g/L L-lactate was accumulated by B0013-090B with the lactate productivity of 4.90 g/Lh and the yield of 93.7% in 27 h from glycerol. The optical purity of L-lactate in broth is above 99.95%.
		                        		
		                        		
		                        		
		                        			Bacillus
		                        			;
		                        		
		                        			enzymology
		                        			;
		                        		
		                        			Cloning, Molecular
		                        			;
		                        		
		                        			Escherichia coli
		                        			;
		                        		
		                        			enzymology
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Glycerol
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			L-Lactate Dehydrogenase
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Lactic Acid
		                        			;
		                        		
		                        			biosynthesis
		                        			;
		                        		
		                        			Metabolic Engineering
		                        			;
		                        		
		                        			Promoter Regions, Genetic
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			Recombinant Proteins
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			
		                        		
		                        	
6.Temperature-switched high-efficiency D-lactate production from glycerol.
Kangming TIAN ; Li ZHOU ; Xianzhong CHEN ; Wei SHEN ; Guiyang SHI ; Suren SINGH ; Fuping LU ; Zhengxiang WANG
Chinese Journal of Biotechnology 2013;29(1):111-114
		                        		
		                        			
		                        			Glycerol from oil hydrolysis industry is being considered as one of the abundent raw materials for fermentation industry. In present study, the aerobic and anaerobic metabolism and growth properties on glycerol by Esherichia coli CICIM B0013-070, a D-lactate over-producing strain constructed previously, at different temperatures were investigated, followed by a novel fermentation process, named temperature-switched process, was established for D-lactate production from glycerol. Under the optimal condition, lactate yield was increased from 64.0% to 82.6%. Subsequently, the yield of D-lactate from glycerol was reached up to 88.9% while a thermo-inducible promoter was used to regulate D-lactate dehydrogenase transcription.
		                        		
		                        		
		                        		
		                        			Aerobiosis
		                        			;
		                        		
		                        			Anaerobiosis
		                        			;
		                        		
		                        			Escherichia coli
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Fermentation
		                        			;
		                        		
		                        			Glycerol
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			L-Lactate Dehydrogenase
		                        			;
		                        		
		                        			metabolism
		                        			;
		                        		
		                        			Lactic Acid
		                        			;
		                        		
		                        			biosynthesis
		                        			;
		                        		
		                        			Promoter Regions, Genetic
		                        			;
		                        		
		                        			genetics
		                        			;
		                        		
		                        			Temperature
		                        			
		                        		
		                        	
7.A clinical analysis of AIDS-related non-Hodgkin lymphoma in 5 patients and review of literature
Guiren RUAN ; Huanling WANG ; Ying GE ; Xiaochun SHI ; Fuping GUO ; Dingrong ZHONG ; Daobin ZHOU ; Taisheng LI
Chinese Journal of Internal Medicine 2012;51(3):184-187
		                        		
		                        			
		                        			Objective To analyze the clinical characteristics of AIDS-related non-Hodgkin lymphoma(ARL)and review relative literature for the diagnosis and treatment of ARL.Method The clinical data of ARL patients admitted to Peking Union Medical College Hospital from April 2009 to April 2011 were retrospectively analyzed.Results Five male ARL patients aged 32 to 65 years old were included in this retrospective study.Among them,two patients were found to be HIV-positive for the first time,three were on regular highly active anti-retroviral therapy(HAART)for 7-8 months before the emergence of lymphoma-related symptoms.CD4+ T cell count was(69-232)× 106/L at presentation.Two patients firstly presented with sore throat and throat ulcer,one with cervical nodules,one with pelvic mass,one with fever and edema in right thigh.Through pathological analysis,four patients had B cell-originated lymphoma,with one Burkitt lymphoma and three diffuse large B cell lymphomas; one patient had T-cell lymphoma.Four patients were treated with chemotherapy,with one complete remission,one relapse,one non-response,and one death.One patient had radiotherapy only and had progressed disease.Bone marrow suppression and gastrointestinal disturbance were the main adverse effects of chemotherapy.Conclusions Lymphoma should be considered in any HIV-infected patients presented with unexplainable adenopathy,recurrent sore throat or throat ulcer,or fever of unknown origin.Biopsy should be rigorously carried out.Appropriate chemotherapy,together with HAART,may improve the prognosis greatly.
		                        		
		                        		
		                        		
		                        	
8.C825T polymorphism of G protein β3 subunit in cerebral infarction patients with a history of hypertension
Hhuiling WANG ; Zhenzhong LI ; Junfeng ZHANG ; Zhizun WANG ; Fuping SHI
International Journal of Cerebrovascular Diseases 2011;19(8):580-584
		                        		
		                        			
		                        			Objective To investigate the relationship between the C825T polymorphism of G protein β3 subunit (GNB3) and essential hypertension and cerebral infarction patients with a history of hypertension. Methods The C825T polymorphism of GNB3 was determined by polymerase chain reaction-restriction fragment length polymorphism in 110 healthy subjects aged over 40 years, 92 patients with essential hypertension, and 80 cerebral infarction patients with a history of hypertension. Sex, age, family histories of diabetics, smoking and alcoholic consumption were documented, and body mass index, waist-hip ratio, total cholesterol (TC),triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), and fasting blood glucose concentration were measured. A multivariate logistic regression analysis was used to screen the factors associated with the occurrence of cerebral infarction in patients with hypertension.Results The distribution of the C825T polymorphism of GNB3 in the 3 groups all met the Hardy-Weinberg Law of genetic equilibrium. The genotype frequencies of CC, CT and TT in cerebral infarction patients with a history of hypertension were 33%, 57%, and 20%, respectively; those in patients with essential hypertension were 33%, 42%, and 25% ; respectively;and those in the control group were 26%, 54%, and 20%, respectively. There were no significant differences (x2 =4. 030, P =0. 402). The allele frequencies of 825T in the 3 groups were 39%, 40%, and 47%, respectively. There were no significant differences (x2 =0. 832). A multivariate logistic regression analysis showed that TC (odds ratio [ OR] 10. 810, 95% confidence interval [ CI] 2. 64544. 136, P =0. 000), TG (OR 5. 453, 95% CI 1.662-17. 881, P =0. 005),HDL-C (OR, 0. 181, 95% CI 0. 041-0. 795, P = 0. 027), blood glucose (OR 2. 386, 95% CI1.062-5. 363, P =0. 035), and diabetes (OR 7. 156, 95% CI 1.271-40. 291, P =0. 026) were the independent risk factors for cerebral infarction, and the GNB3 genotype and allele did not enter the model. Conclusions The C825T polymorphism of GNB3 may not be associated with cerebral infarction and essential hypertension.
		                        		
		                        		
		                        		
		                        	
9.Human cytomegalovirus infection concerned with carotid atherosclerosis
Weiying DI ; Fuping SHI ; Liping LIU ; Yanfei WANG ; Guohua ZHANG ; Tongkai LI ; Dechao WANG
Clinical Medicine of China 2011;27(11):1176-1178
		                        		
		                        			
		                        			Objective To study the correlation of human cytomegalovirus infection with carotid atherosclerosis.Methods A total of 120 patients with carotid atherosclerosis and 140 healthy control patients were recruited for HCMV-PP65 antigen detection and Ultrasound examination.Results In carotid atherosclerosis and healthy patients,58.20%(71 cases)and 6.43%(9 cases)of the subjects were positive for HCMV-PP65 antigen(x2 =32.98,P < 0.05).In carotid atherosclerosis group,69.01%(49 cases)of the patients with positive HCMV-PP65 antigen had instable plaques,while it was 47.06%(24 cases)in the patients with negative HCMV-PP65 antigen.The difference in the positivity of HCMV-PP65 between the two groups were significant(x2 =8.22,P < 0.05).Conclusion Active infection of HCMV may be associated with Carotid Atherosclerosis and the plaques will be more instable.
		                        		
		                        		
		                        		
		                        	
10.Mesenchymal stem cell and its application in the treatment of liver disease
International Journal of Biomedical Engineering 2011;34(5):309-313
		                        		
		                        			
		                        			Mesenchymal stem cells (MSCs) have been the hot spot of rehabilitation and tissue engineered medicine.Due to their origination from the adult tissues,the multilineage differentiation potential and immune escape characteristics,MSCs become the ideal seed cells for cell transplant treatment.This article summarizes the biological characteristics of MSCs and its application in the treatment of liver disease.
		                        		
		                        		
		                        		
		                        	
            
Result Analysis
Print
Save
E-mail